ResearcherGuangxi Medical UniversityActive in the last 2 years
Zhihai Liang
Matched on ORCID iD 0000-0001-5348-0130; OpenAlex author ID A5044031919. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study. First author DOI 10.1111/jcmm.18255↗
- KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma. Last author DOI 10.2147/ijgm.s313584↗
- Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis. Last author DOI 10.3934/mbe.2021296↗
- Activation of the Nuclear Factor-kappa B Signaling Pathway Damages the Epithelial Barrier in the Human Pancreatic Ductal Adenocarcinoma Cell Line HPAF-II. Last author DOI 10.1097/mpa.0000000000001441↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xin Li · 1 shared paper, 2024 · strength 0.46
- Yuexian Li · 2 shared papers, 2021 · strength 0.36
- Paper KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocar… DOI 10.2147/ijgm.s313584↗
- Paper Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarci… DOI 10.3934/mbe.2021296↗
- Siyuan Zhou · 2 shared papers, 2019–2021 · strength 0.32
- Paper KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocar… DOI 10.2147/ijgm.s313584↗
- Paper Activation of the Nuclear Factor-kappa B Signaling Pathway Damages the Epithelial Barrier in the Human Pancreatic Ducta… DOI 10.1097/mpa.0000000000001441↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.